2013Journal of Hepatobiliary SurgeryRequires access

PTCD with metallic stent for malignent obstructive jaundice

Hao Yu-zh

Open publisher page 0 citations

Abstract

Objective To investigate the effect of percutaneous transhepatic cholangial drainage( PTCD) for treatment of malignant obstructive jaundice with metallic stent. Methods 19 patients with malignant t biliary obstruction were treated by the were treated by PTCD with metallic stent. Result The technical successful rate was 100%,Before surgery,total serum bilirubin level was at( 228.9 ±30. 2) μmol/L.2 weeks after surgery,total serum bilirubin level was down to( 167.4 ±42. 1) μmol/L( P 0. 05). There were8 patients with complication after surgery. There were 2 cases with biliary tract bleeding,5 cases with biliary tract infection,1case with stent blocking and 1case with bile leaking. All the cases were controled by effective clinical treatment. Conclusions Treating obstructive jaundice with PTCD and metallic stent is safety and effective and it is a palliative therapy for treating malignant obstructive jaundice.

About this research paper

What this paper is about

Objective To investigate the effect of percutaneous transhepatic cholangial drainage( PTCD) for treatment of malignant obstructive jaundice with metallic stent. Methods 19 patients with malignant t biliary obstruction were treated by the were treated by PTCD with metallic stent. Result The technical successful rate was 100%,Before surgery,total serum bilirubin level was at( 228.9 ±30. 2) μmol/L.2 weeks after surgery,total serum bilirubin level was down to( 167.4 ±42. 1) μmol/L( P 0. 05). There were8 patients with complication after surgery. There were 2 cases with biliary tract bleeding,5 cases with biliary tract infection,1case with stent blocking and 1case with bile leaking. All the cases were controled by effective clinical treatment. Conclusions Treating obstructive jaundice with PTCD and metallic stent is safety and effective and it is a palliative therapy for treating malignant obstructive jaundice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of percutaneous transhepatic cholangial drainage( PTCD) for treatment of malignant obstructive jaundice with metallic stent. Methods 19 patients with malignant t biliary obstruction were treated by the were treated by PTCD with metallic stent. Result The technical successful rate was 100%,Before surgery,total serum bilirubin level was at( 228.9 ±30. 2) μmol/L.2 weeks after surgery,total serum bilirubin level was down to( 167.4 ±42. 1) μmol/L( P 0. 05). There were8 patients with complication after surgery. There were 2 cases with biliary tract bleeding,5 cases with biliary tract infection,1case with stent blocking and 1case with bile leaking. All the cases were controled by effective clinical treatment. Conclusions Treating obstructive jaundice with PTCD and metallic stent is safety and effective and it is a palliative therapy for treating malignant obstructive jaundice.

Key concepts: Medicine, Obstructive jaundice, Stent, Jaundice, Percutaneous, Complication, Biliary tract, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
PTCD with metallic stent for malignent obstructive jaundice — Research Paper | ScholarLens